IAVI Announces First Vaccinations at Liberia Site in Phase I Clinical Trial of Lassa Fever Vaccine Candidate

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://www.iavi.org/news-resources/press-releases/2022/iavi-announces-first-vaccinations-at-liberia-site-in-phase-i-clinical-trial-of-lassa-fever-vaccine-candidate
Research Institution
IAVI
Short Title
IAVI Announces First Vaccinations at Liberia Site in Phase I Clinical Trial of Lassa Fever Vaccine Candidate
Content Coordinator
Claudia Wair
Content Manager
Catey Laube Macdonald